The University of Houston in partnership with Humana is now offering a six-course, fully online program focusing on value-based care. Photo via UH.edu

Last week, the University of Houston announced a new online program that will provide specialized value-based care training for providers, academia and other business and industry professionals.

UH teamed up with Kentucky-based health insurance giant, Humana, to create the new Value-based Care Specialization program that will teach the fundamentals and real-world application of value-based care. The flexible, fully-online program is being provided via the collaborative Humana Integrated Health System Sciences Institute and through global online learning platform Coursera.

"This readily available and affordable option will support those who are working with practices and providers to create better outcomes for their patients," says Tray Cockerell, director of strategy advancement for Humana, in a news release. "It's more important than ever, with the tumult caused by COVID-19, that practices focus on prevention and care coordination.

"We learned in 2020 that providers in value-based care agreements were better positioned to withstand the financial impact the pandemic brought on the health care industry because they had established patient-centered medical practices.," he continues. "Because they could quickly pivot their resources into action to best serve patients, their income was not as drastically affected as those of their fee-for-service peers."

Recent surveys have shown that there is a varied understanding of the definition of value-based care within the health care industry, and now more than ever there is a need to retool the workforce.

"It's essential that those who work to improve the health of their communities speak the same language," says Dr. LeChauncy Woodard, general internist and founding director, Humana Integrated Health System Sciences Institute at the University of Houston, in the release. "The collaboration on this content assures that everyone, from the physician and nurse, to social workers, pharmacists and claims representatives, as well as consumers of health care understand what it takes to work together. These multisector partnerships help to ensure patients are receiving the best possible care and achieving the best outcomes at the lowest possible cost."

The program consists of six courses and a capstone project, and each course features a few learning modules and a summative assignment. Participants can take any of the six courses independently — receiving a certificate for each — or collectively for the specialization designation, per the release.

"The health care industry is rapidly changing, and high-quality, flexible learning can help support medical professionals preparing for the future," says Betty Vandenbosch, chief content officer at Coursera, in the release. "We are excited to partner with leaders such as the University of Houston and Humana to offer job-relevant content in the emerging area of value-based care."

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

Austin company to bring AI-powered school to The Woodlands

AI education

Austin-based Alpha School, which operates AI-powered private schools, is opening its first Houston-area location in The Woodlands.

The 8,000-square-foot school, scheduled to be ready for the 2026-27 academic year, initially will serve students in kindergarten through eighth grade. Alpha says the school will offer “open workshop spaces and innovative classrooms that support personalized instruction, core academics, leadership development, and real-world life skills.”

Alpha sets aside two hours each school day for the AI-driven, self-paced study of core subjects like math, reading and science. The rest of each school day consists of life-skills workshops focusing on topics such as leadership and financial literacy.

Alpha’s school in The Woodlands has begun accepting applications for the 2026-27 school year. Annual tuition costs $40,000.

“The Woodlands is one of the most dynamic, forward-thinking communities in Texas, and Alpha is proud to bring

an innovative educational model that complements its strong academic foundation,” says Rachel Goodlad, head

of expansion for Alpha.

Founded in 2014, Alpha School combines adaptive technology-driven instruction with immersive life-skills workshops. Its model emphasizes mastery-based learning in core subjects alongside development of communication, critical thinking, financial literacy and leadership skills. It operates more than 15 schools across the country.

Elsewhere in Texas, Alpha operates schools in Austin, Brownsville, Fort Worth and Plano. Alpha also operates 12 Texas Sports Academy campuses in Texas, including locations in Houston, Pearland and Richmond, along with a NextGen Academy esports school in Austin, a school for gifted students in Georgetown, and lower-cost Nova Academy campuses in Austin and Bastrop.

Alpha has fans and critics. While supporters tout students’ high achievement rates, detractors complain about the high tuition and the AI-influenced depersonalization of education.

“Students and our country need to be in relationship with other human beings,” Randi Weingarten, president of the American Federation of Teachers, a teachers union, tells The New York Times. “When you have a school that is strictly AI, it is violating that core precept of the human endeavor and of education.”

Alpha co-founder MacKenzie Price, a podcaster and social media influencer, doesn’t share Weingarten’s views.

“Parents and teachers: We need to embrace this change,” Price wrote after President Trump signed an executive order promoting AI in schools.

The Times notes that Alpha doesn’t employ AI as a tutor or a supplement. Rather, the newspaper says, AI is “the school’s primary educational driver to move students through academic content.”

Houston researcher secures $1.7M to develop drug for aggressive form of breast cancer

cancer research

A University of Houston researcher has joined a $3.2 million effort to develop a new drug designed to attack a cancer-driving protein commonly found in triple-negative breast cancer.

Triple-negative breast cancer (TNBC) is one of the most difficult-to-treat forms of cancer and accounts for 10 percent to 15 percent of all breast cancer cases. The disease gets its name because tumors associated with it test negative for estrogen receptors, progesterone receptors and excess HER2 protein, making it difficult to target. Due to this, TNBC is often treated with general chemotherapy, which can come with negative side effects and drug resistance, according to UH.

UH College of Pharmacy research associate professor Wei Wang is developing a drug that can target the disease more specifically. The drug will target MDM2, a protein often overproduced in TNBC that also contributes to faster tumor growth.

Wang is working on a team led by Wei Li, director of the University of Tennessee Health Science Center College of Pharmacy’s Drug Discovery Center. She has received $1.7 million to support the research.

Wang and UH professor of pharmacology and toxicology Ruiwen Zhang have discovered a compound that can break down MDM2. In early laboratory models, the compound has shown the ability to shrink tumors.

Wang and Zhang will focus on understanding how the treatment works and monitoring its effectiveness in models that closely mirror human disease.

“We will study how the drug targets MDM2 and evaluate the most promising drug candidates to determine effective dosing, understand how the drug behaves in the body, compare it with existing treatments and assess early safety,” Wang said in a news release.

Li’s team at the University of Tennessee will be working on the chemistry and drug design end of the project.

“This work could lead to an entirely new class of therapies for triple-negative breast cancer,” Li added in the release. “We’re hopeful that by directly removing the MDM2 protein from cancer cells, we can help more patients respond to treatment regardless of their tumor type.”